We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
(-11%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102
Avg Time Held Equity + Options
1.8
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.64M |
| 2 |
Lindsay Corp
LNN
|
+$2.12M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.77M |
| 4 |
Boston Scientific
BSX
|
+$1.51M |
| 5 |
Verizon
VZ
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.34M |
| 2 |
3D Systems Corp
DDD
|
+$1.86M |
| 3 |
Lennar Class A
LEN
|
+$989K |
| 4 |
BlackBerry
BB
|
+$938K |
| 5 |
Vince Holding Corp
VNCE
|
+$928K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.91% |
| 2 | Miscellaneous | 27.85% |
| 3 | Healthcare | 13.47% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
HomeTrust Bancshares
HTB
$758M
| $316K | 0.17% |
20,000
| – | – |
2013 Q2
3 quarters
|
|
127
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $316K | 0.17% |
50,000
| – | – |
2013 Q2
3 quarters
|
|
|
SQBK
128
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $310K | 0.17% |
+15,400
| New | +$314K |
2014 Q1
0 quarters
|
|
|
STKL
129
DELISTED
SunOpta
STKL
| $296K | 0.16% |
+25,030
| New | +$251K |
2014 Q1
0 quarters
|
|
|
CIMT
130
CALL
DELISTED
CIMATRON LTD ORD SHS
CIMT
| $295K | 0.16% |
+40,800
| New | +$364K |
2014 Q1
0 quarters
|
|
131
CALL
Weyerhaeuser
WY
$13.7B
| $294K | 0.16% |
10,000
-40,000
| -80% | -$1.2M |
2013 Q4
1 quarter
|
|
132
Abercrombie & Fitch
ANF
$6.19B
| $289K | 0.16% |
7,500
| – | – |
2013 Q4
1 quarter
|
|
133
Herbalife
HLF
$1.43B
| $286K | 0.15% |
+10,000
| New | +$330K |
2014 Q1
0 quarters
|
|
|
GKNT
134
DELISTED
GEEKNET INC COM NEW
GKNT
| $280K | 0.15% |
20,000
| – | – |
2013 Q2
3 quarters
|
|
135
Archer Daniels Midland
ADM
$38.8B
| $274K | 0.15% |
6,309
| – | – |
2013 Q2
3 quarters
|
|
|
MDRX
136
DELISTED
Veradigm Inc. Common Stock
MDRX
| $270K | 0.15% |
15,000
-5,000
| -25% | -$86.5K |
2013 Q2
3 quarters
|
|
137
CALL
DELISTED
Equity Commonwealth
EQC
| $263K | 0.14% |
+10,000
| New | +$256K |
2014 Q1
0 quarters
|
|
|
SEAC
138
DELISTED
Seachange International Inc
SEAC
| $261K | 0.14% |
1,250
-250
| -17% | -$56.8K |
2013 Q2
3 quarters
|
|
|
XLRN
139
DELISTED
Acceleron Pharma
XLRN
| $259K | 0.14% |
+7,500
| New | +$338K |
2014 Q1
0 quarters
|
|
140
CALL
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $246K | 0.13% |
40,000
+30,000
| +300% | +$187K |
2013 Q3
2 quarters
|
|
141
DELISTED
Manitex International, Inc.
MNTX
| $245K | 0.13% |
15,000
| – | – |
2013 Q4
1 quarter
|
|
|
142
CALL
BlackBerry
BB
$4.96B
| $242K | 0.13% |
30,000
-230,000
| -88% | -$2.16M |
2013 Q4
1 quarter
|
|
143
Tvardi Therapeutics
TVRD
$14.1M
| $242K | 0.13% |
+361
| New | +$214K |
2014 Q1
0 quarters
|
|
|
QTWW
144
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
| $242K | 0.13% |
+25,000
| New | +$217K |
2014 Q1
0 quarters
|
|
145
DELISTED
Craft Brew Alliance, Inc.
BREW
| $229K | 0.12% |
15,000
| – | – |
2013 Q2
3 quarters
|
|
146
DELISTED
Kennedy-Wilson Holdings
KW
| $225K | 0.12% |
10,000
| – | – |
2013 Q4
1 quarter
|
|
|
NADL
147
DELISTED
North Atlantic Drilling Ltd
NADL
| $221K | 0.12% |
+2,500
| New | +$219K |
2014 Q1
0 quarters
|
|
148
Archrock
AROC
$5.32B
| $219K | 0.12% |
+5,000
| New | +$186K |
2014 Q1
0 quarters
|
|
|
LUB
149
DELISTED
Luby's Inc.
LUB
| $216K | 0.12% |
35,000
| – | – |
2013 Q2
3 quarters
|
|
|
JCP
150
DELISTED
J.C. Penney Company, Inc.
JCP
| $216K | 0.12% |
25,000
-25,000
| -50% | -$181K |
2013 Q4
1 quarter
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2014 Portfolio in Review
As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
- E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
- E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
- E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
- E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
- E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
- E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.
Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.